Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental macromolecular aerosol therapy.

B K Rubin1

  • 1Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1081, USA. brubin@wfubmc.edu

Respiratory Care
|July 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Year in review: "Best" papers in pediatric pulmonary and sleep medicine in 2025.

Paediatric respiratory reviews·2026
Same author

Rational use of mucoactive medications to treat pediatric airway disease.

Paediatric respiratory reviews·2020
Same author

Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.

Respiratory medicine·2015
Same author

IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat.

Zoonoses and public health·2012
Same author

IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011
Same journal

Response to the Letter to the Editor Regarding "Comparative Evaluation of Risk Scores for Predicting Postoperative Pulmonary Complications".

Respiratory care·2026
Same journal

Respiratory Muscle Dysfunction in Stable COPD: A Multimodal Assessment of Diaphragmatic and Cough-Related Impairment.

Respiratory care·2026
Same journal

Flow Asynchronies During Pressure Support Ventilation in Children: A Bench Model Study.

Respiratory care·2026
Same journal

Inspiratory Effort Assessment Using the Occlusion Pressure-Derived Tension-Time Index.

Respiratory care·2026
Same journal

Clinical Usage of High-Flow Nasal Cannula Across Disease Categories and Care Settings: A Nationwide Cohort Study in Japan.

Respiratory care·2026
Same journal

Efficacy of Mechanical Insufflation-Exsufflation Devices as Analyzed in Lung Models: Systematic Review and Network Meta-Analysis of Peak Expiratory Flow Data.

Respiratory care·2026
See all related articles

Novel experimental therapies are emerging that could significantly change how we understand and treat airway diseases. These advancements mark a pivotal moment in respiratory medicine.

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Translational Medicine

Background:

  • Airway diseases represent a significant global health burden.
  • Current treatment paradigms for airway diseases are limited in efficacy for many patients.

Purpose of the Study:

  • To review and highlight emerging novel and experimental therapies for airway diseases.
  • To discuss the potential impact of these therapies on the understanding and management of airway conditions.

Main Methods:

  • Literature review of recent preclinical and clinical studies.
  • Analysis of emerging therapeutic strategies targeting airway inflammation and remodeling.
  • Synthesis of current research trends in airway disease treatment.

Main Results:

Related Experiment Videos

  • Identification of several promising experimental therapies, including biologics and gene therapies.
  • These therapies demonstrate potential for disease modification beyond symptom control.
  • Early data suggests a paradigm shift in therapeutic approaches is feasible.

    • Conclusions:

    • Novel and experimental therapies hold significant promise for transforming the management of airway diseases.
    • These advancements necessitate a re-evaluation of our fundamental understanding of airway pathophysiology.
    • The field is rapidly evolving, offering hope for improved patient outcomes.